Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7825)
All Articles published online
|
Publishing Process of This Article
|
Nov 7, 2014 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | De Divitiis C, Nasti G, Montano M, Fisichella R, Iaffaioli RV, Berretta M. Prognostic and predictive response factors in colorectal cancer patients: Between hope and reality. World J Gastroenterol 2014; 20(41): 15049-15059 [PMID: 25386053 DOI: 10.3748/wjg.v20.i41.15049] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i41/15049.htm |
| Number | Citing Articles |
| 1 |
Zhi-Yu Song, Zu-Hua Gao, Jia-Hui Chu, Xiu-Zhen Han, Xian-Jun Qu. Downregulation of the CXCR4/CXCL12 axis blocks the activation of the Wnt/β-catenin pathway in human colon cancer cells. Biomedicine & Pharmacotherapy 2015; 71: 46 doi: 10.1016/j.biopha.2015.01.020
|
| 2 |
Hsin‐Yin Hsu, Yih‐Jong Chern, Min‐Shu Hsu, Tzu‐Lin Yeh, Ming‐Chieh Tsai, Jing‐Rong Jhuang, Lee‐Ching Hwang, Chun‐Ju Chiang, Wen‐Chung Lee, Kuo‐Liong Chien. Diabetic severity and oncological outcomes of colorectal cancer following curative resection: A population‐based cohort study in Taiwan. Cancer 2023; 129(24): 3928 doi: 10.1002/cncr.34975
|
| 3 |
Ashini H. Shah, Amisha J. Gami, Neetal H. Desai, Jahnavi S. Gandhi, Priti P. Trivedi. Tumor budding as a prognostic indicator in colorectal carcinoma: a retrospective study of primary colorectal carcinoma cases in a tertiary care center. Indian Journal of Surgical Oncology 2022; 13(3): 459 doi: 10.1007/s13193-022-01498-7
|
| 4 |
C. Mekouba Etongo, H. Vincent, M. Harboun. Impact de l’évaluation gériatrique standardisée sur la survie de patients de plus de 75 ans hospitalisés dans un service d’oncogériatrie. NPG Neurologie - Psychiatrie - Gériatrie 2024; 24(139): 24 doi: 10.1016/j.npg.2023.05.009
|
| 5 |
Kaitlyn K.H. Goey, Remi Mahmoud, Halfdan Sørbye, Bengt Glimelius, Claus-Henning Köhne, Daniel J. Sargent, Cornelis J.A. Punt, Martijn G.H. van Oijen, Miriam Koopman. Reporting of patient characteristics and stratification factors in phase 3 trials investigating first-line systemic treatment of metastatic colorectal cancer: A systematic review. European Journal of Cancer 2018; 96: 115 doi: 10.1016/j.ejca.2018.03.026
|
| 6 |
Moon Suk Choi, Jung Wook Huh, Jung Kyong Shin, Yoon Ah Park, Yong Beom Cho, Hee Cheol Kim, Seong Hyeon Yun, Woo Yong Lee. Prognostic Factors and Treatment of Recurrence after Local Excision of Rectal Cancer. Yonsei Medical Journal 2021; 62(12): 1107 doi: 10.3349/ymj.2021.62.12.1107
|
| 7 |
Hasan Mollanoori, Yaser Ghelmani, Bita Hassani, Mohammadreza Dehghani. Integrated whole transcriptome profiling revealed a convoluted circular RNA-based competing endogenous RNAs regulatory network in colorectal cancer. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-023-50230-0
|
| 8 |
Yun Qian, Yu-Jiang Li, Yi-Wei Fu, Cui-Xia Liu, Juan Wang, Bin Yang, Luca Falzone. tRNA-Uridine Aminocarboxypropyltransferase DTW Domain Containing 2 Suppresses Colon Adenocarcinoma Progression. International Journal of Genomics 2023; 2023: 1 doi: 10.1155/2023/4354536
|
| 9 |
Catherine G. Tran, Paolo Goffredo, Sarah L. Mott, Alexander Hart, Y. Nancy You, Jean-Nicolas Vauthey, Ronald J. Weigel, Imran Hassan. The impact of KRAS mutation, microsatellite instability, and tumor laterality on the prognosis of nonmetastatic colon cancer. Surgery 2022; 171(3): 657 doi: 10.1016/j.surg.2021.10.043
|
| 10 |
Kseniya Ruksha, Artur Mezheyeuski, Alexander Nerovnya, Tatyana Bich, Gennady Tur, Julia Gorgun, Richard Luduena, Anna Portyanko. Over-Expression of βII-Tubulin and Especially Its Localization in Cell Nuclei Correlates with Poorer Outcomes in Colorectal Cancer. Cells 2019; 8(1): 25 doi: 10.3390/cells8010025
|
| 11 |
Ioannis Sougklakos, Elias Athanasiadis, Ioannis Boukovinas, Michalis Karamouzis, Aggelos Koutras, Paulos Papakotoulas, Dimitra Latsou, Magda Hatzikou, Eugena Stamuli, Athanasios Balasopoulos, Aggelos Sideris. Treatment pathways and associated costs of metastatic colorectal cancer in Greece. Cost Effectiveness and Resource Allocation 2022; 20(1) doi: 10.1186/s12962-022-00339-2
|
| 12 |
Gulcan Bulut, Zehra Narli Ozdemir. Prognostic Significance of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Metastatic Colorectal Cancer. Journal of Gastrointestinal Cancer 2022; 53(1): 1 doi: 10.1007/s12029-021-00616-y
|
| 13 |
Mehmet Artaç, Bassel F. El-Rayes, Suayib Yalcin, Philip A. Philip. Textbook of Gastrointestinal Oncology. 2019; : 161 doi: 10.1007/978-3-030-18890-0_9
|
| 14 |
Patrycja Przygodzka, Izabela Papiewska-Pajak, Helena Bogusz, Jakub Kryczka, Katarzyna Sobierajska, M. Anna Kowalska, Joanna Boncela. Neuromedin U is upregulated by Snail at early stages of EMT in HT29 colon cancer cells. Biochimica et Biophysica Acta (BBA) - General Subjects 2016; 1860(11): 2445 doi: 10.1016/j.bbagen.2016.07.012
|
| 15 |
J. Feliu, I. Díez de Corcuera, J. L. Manzano, M. Valladares-Ayerbes, J. Alcaide, T. García García, R. Vera, J. Sastre. Effectiveness and safety of aflibercept for metastatic colorectal cancer: retrospective review within an early access program in Spain. Clinical and Translational Oncology 2017; 19(4): 498 doi: 10.1007/s12094-016-1556-3
|
| 16 |
Amal Rayan, Ahmed Soliman, Norikatsu Miyoshi. Applying a neoscore in locally advanced rectal cancer is beneficial in predicting local recurrences after surgery. PLOS ONE 2023; 18(5): e0285709 doi: 10.1371/journal.pone.0285709
|
| 17 |
Vinod Sharma, Atul Sharma, Vinod Raina, Deepak Dabkara, Bidhu Kalyan Mohanti, N. K. Shukla, Sushmita Pathy, Sanjay Thulkar, S. V. S. Deo, Sunil Kumar, Ranjit Kumar Sahoo. Metastatic colo-rectal cancer: real life experience from an Indian tertiary care center. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08398-z
|
| 18 |
Alberto D’Angelo, Navid Sobhani, Giandomenico Roviello, Stefan Bagby, Deborah Bonazza, Cristina Bottin, Fabiola Giudici, Fabrizio Zanconati, Nicolo De Manzini, Alessandra Guglielmi, Daniele Generali, Ilse Rooman. Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma. PLOS ONE 2019; 14(8): e0219566 doi: 10.1371/journal.pone.0219566
|
| 19 |
Georgios Koimtzis, Georgios Geropoulos, Leandros Stefanopoulos, Christopher Gwydion Chalklin, Ioannis Karniadakis, Vyron Alexandrou, Nikos Tteralli, Eliot Carrington-Windo, Andreas Papacharalampous, Kyriakos Psarras. The Role of Carbon Nanoparticles as Lymph Node Tracers in Colorectal Cancer: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences 2023; 24(20): 15293 doi: 10.3390/ijms242015293
|
| 20 |
Ersin Ozaslan, Ayse Ocak Duran, Oktay Bozkurt, Mevlude Inanc, Mahmut Ucar, Veli Berk, Halit Karaca, Ferhan Elmali, Metin Ozkan. Analyses of Multiple Factors for Determination of "Selected Patients" Who Should Receive Rechallenge Treatment in Metastatic Colorectal Cancer: a Retrospective Study from Turkey. Asian Pacific Journal of Cancer Prevention 2015; 16(7): 2833 doi: 10.7314/APJCP.2015.16.7.2833
|
| 21 |
Wenjun Luo, Diao He, Jianhao Zhang, Zida Ma, Keling Chen, Zhaoying lv, Chuanwen Fan, Lie Yang, Yuan Li, Zongguang Zhou. Knockdown of PPARδ Induces VEGFA-Mediated Angiogenesis via Interaction With ERO1A in Human Colorectal Cancer. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.713892
|
| 22 |
Eric Van Cutsem, Robert J. Mayer, Stéphanie Laurent, Robert Winkler, Cristina Grávalos, Manuel Benavides, Federico Longo-Munoz, Fabienne Portales, Fortunato Ciardiello, Salvatore Siena, Kensei Yamaguchi, Kei Muro, Tadamichi Denda, Yasushi Tsuji, Lukas Makris, Patrick Loehrer, Heinz-Josef Lenz, Atsushi Ohtsu. The subgroups of the phase III RECOURSE trial of trifluridine/tipiracil (TAS-102) versus placebo with best supportive care in patients with metastatic colorectal cancer. European Journal of Cancer 2018; 90: 63 doi: 10.1016/j.ejca.2017.10.009
|
| 23 |
Sheng Zhang, Yi Xin Tong, Xiang Shang Xu, Hui Lin, Teng Fei Chao. Prognostic significance of SATB1 in gastrointestinal cancer: a meta-analysis and literature review. Oncotarget 2017; 8(29): 48410 doi: 10.18632/oncotarget.16867
|
| 24 |
Wu Bi, Haibo Liu, Jie Shen, Ling-hua Zhang, Pei Li, Bing Peng, Li Cao, Pengfei Zhang, Chunnian He, Peigen Xiao. Chemopreventive effects of Ku-jin tea against AOM-induced precancerous colorectal lesions in rats and metabolomic analysis. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-16237-0
|
| 25 |
Ana Fernández Montes, Carlos López López, Guillem Argilés Martínez, David Páez López, Ana María López Muñoz, Beatriz García Paredes, David Gutiérrez Abad, Carmen Castañón López, Paula Jiménez Fonseca, Javier Gallego Plazas, María Carmen López Doldán, Eva Martínez de Castro, Manuel Sánchez Cánovas, María Tobeña Puyal, Beatriz Llorente Ayala, Ignacio Juez Martel, Mariana López Flores, Alberto Carmona-Bayonas. Prognostic Nomogram and Patterns of Use of FOLFIRI-Aflibercept in Advanced Colorectal Cancer: A Real-World Data Analysis. The Oncologist 2019; 24(8): e687 doi: 10.1634/theoncologist.2018-0824
|
| 26 |
Sami Antoun, Mohamed Amine Bayar, Valérie Dyevre, Emilie Lanoy, Cristina Smolenschi, Michel Ducreux. No evidence for changes in skeletal muscle mass or weight during first-line chemotherapy for metastatic colorectal cancer. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-6086-2
|
| 27 |
Roberto García-Figueiras, Sandra Baleato-González, Anwar R. Padhani, Ana Marhuenda, Antonio Luna, Lidia Alcalá, Ana Carballo-Castro, Ana Álvarez-Castro. Advanced imaging of colorectal cancer: From anatomy to molecular imaging. Insights into Imaging 2016; 7(3): 285 doi: 10.1007/s13244-016-0465-x
|
| 28 |
Johanna C. Bendell, Howard Hochster, Lowell L. Hart, Irfan Firdaus, Joseph R. Mace, Joshua J. McFarlane, Mark Kozloff, Daniel Catenacci, Jessie J. Hsu, Stephen P. Hack, David S. Shames, See-Chun Phan, Hartmut Koeppen, Allen L. Cohn. A Phase II Randomized Trial (GO27827) of First-Line FOLFOX Plus Bevacizumab with or Without the MET Inhibitor Onartuzumab in Patients with Metastatic Colorectal Cancer. The Oncologist 2017; 22(3): 264 doi: 10.1634/theoncologist.2016-0223
|
| 29 |
Mate Naszai, Alina Kurjan, Timothy S. Maughan. The prognostic utility of pre‐treatment neutrophil‐to‐lymphocyte‐ratio (NLR) in colorectal cancer: A systematic review and meta‐analysis. Cancer Medicine 2021; 10(17): 5983 doi: 10.1002/cam4.4143
|
| 30 |
Lu Han, Fangming Gong, Xuxiaochen Wu, Wanxiangfu Tang, Hua Bao, Yue Wang, Daizhenru Wang, Yulan Sun, Peng Li. Comprehensive characterization of PKHD1 mutation in human colon cancer. Cancer Medicine 2024; 13(1) doi: 10.1002/cam4.6796
|
| 31 |
Wey-Ran Lin, Jy-Ming Chiang, Kung-Hao Liang, Siew-Na Lim, Ming-Wei Lai, Yung-Kuan Tsou, Tzu-Yun Hsieh, Chih-Kai Hsu, Chau-Ting Yeh. GALNT14 Genotype Predicts Postoperative Outcome of Stage III Colorectal Cancer With Oxaliplatin as Adjuvant Chemotherapy. Medicine 2016; 95(17): e3487 doi: 10.1097/MD.0000000000003487
|
| 32 |
Elena A. Pudova, Anna V. Kudryavtseva, Maria S. Fedorova, Andrew R. Zaretsky, Dmitry S. Shcherbo, Elena N. Lukyanova, Anatoly Y. Popov, Asiya F. Sadritdinova, Ivan S. Abramov, Sergey L. Kharitonov, George S. Krasnov, Kseniya M. Klimina, Nadezhda V. Koroban, Nadezhda N. Volchenko, Kirill M. Nyushko, Nataliya V. Melnikova, Maria A. Chernichenko, Dmitry V. Sidorov, Boris Y. Alekseev, Marina V. Kiseleva, Andrey D. Kaprin, Alexey A. Dmitriev, Anastasiya V. Snezhkina. HK3 overexpression associated with epithelial-mesenchymal transition in colorectal cancer. BMC Genomics 2018; 19(S3) doi: 10.1186/s12864-018-4477-4
|
| 33 |
Omar Abdel-Rahman. Impact of Sex on Chemotherapy Toxicity and Efficacy Among Patients With Metastatic Colorectal Cancer: Pooled Analysis of 5 Randomized Trials. Clinical Colorectal Cancer 2019; 18(2): 110 doi: 10.1016/j.clcc.2018.12.006
|
| 34 |
Cheng-Ann Winston Ng, Amy Aimei Jiang, Emma Min Shuen Toh, Cheng Han Ng, Zhi Hao Ong, Siyu Peng, Hui Yu Tham, Raghav Sundar, Choon Seng Chong, Chin Meng Khoo. Metformin and colorectal cancer: a systematic review, meta-analysis and meta-regression. International Journal of Colorectal Disease 2020; 35(8): 1501 doi: 10.1007/s00384-020-03676-x
|
| 35 |
Maha-Hamadien Abdulla, Shaik Sultana, Mansoor-Ali Vaali‑Mohammed, Khayal Al Khayal, Thamer Traiki, Ahmad Zubaidi, Tariq Al‑Johani, Zahid Shakoor, Omar Abdullah‑Al Obeed. Expression of VEGF, EGF and HGF in early‑ and late‑stage colorectal cancer. Molecular and Clinical Oncology 2021; 15(6) doi: 10.3892/mco.2021.2413
|
| 36 |
Jesús Daniel Fernández-de Castro, Franco Baiocchi Ureta, Raquel Fernández González, Noel Pin Vieito, Joaquín Cubiella Fernández. Efecto de la demora atribuible al sistema sanitario en el pronóstico del cáncer colorrectal. Gastroenterología y Hepatología 2019; 42(9): 527 doi: 10.1016/j.gastrohep.2019.03.012
|
| 37 |
Mashaal Dhir, Lekshmi Ramalingam, Yongli Shuai, Sam Pakrafter, Heather L. Jones, Melissa E. Hogg, Amer H. Zureikat, Matthew P. Holtzman, Steven A. Ahrendt, Nathan Bahary, James F. Pingpank, Herbert J. Zeh, David L. Bartlett, Haroon A. Choudry. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion in Adolescent and Young Adults with Peritoneal Metastases. Annals of Surgical Oncology 2017; 24(4): 875 doi: 10.1245/s10434-016-5689-y
|
| 38 |
Pooneh Mokarram, Mehrdad Asghari Estiar, Hassan Ashktorab. Epigenetics Territory and Cancer. 2015; : 373 doi: 10.1007/978-94-017-9639-2_13
|
| 39 |
Xiaoming Shi, Wei Zhao, Yongbin Yang, Shengchun Wu, Bonan Lv. Salidroside could enhance the cytotoxic effect of L‑OHP on colorectal cancer cells. Molecular Medicine Reports 2017; doi: 10.3892/mmr.2017.7846
|
| 40 |
Xuan Dong, Yong Huang, Lingbin Kong, Jin Li, Jingxuan Kou, Lixin Yin, Jingyu Yang. C35 is overexpressed in colorectal cancer and is associated tumor invasion and metastasis. BioScience Trends 2015; 9(2): 117 doi: 10.5582/bst.2015.01057
|
| 41 |
The Chicago Consensus on peritoneal surface malignancies: Management of colorectal metastases. Cancer 2020; 126(11): 2534 doi: 10.1002/cncr.32874
|
| 42 |
Samvel Bardakhchyan, Sergo Mkhitaryan, Davit Zohrabyan, Liana Safaryan, Armen Avagyan, Lilit Harutyunyan, Jemma Arakelyan, Gevorg Tamamyan, Armen Tananyan. Treatment and Outcomes of Colorectal Cancer in Armenia: A Real-World Experience From a Developing Country. JCO Global Oncology 2020; (6): 1286 doi: 10.1200/GO.20.00251
|
| 43 |
Ariunzaya Batjargal, Przemyslaw Solek, Wirginia Kukula-Koch, Baigalmaa Urjin, Wojciech Koch, Dorota Koman, Ewa Dudzinska. Gurgem-7 toxicity assessment: Regulation of cell survival or death by traditional Mongolian prescription. Ecotoxicology and Environmental Safety 2022; 239: 113660 doi: 10.1016/j.ecoenv.2022.113660
|
| 44 |
Francesco Fiorica, Marco Trovò, Gabriele Anania, Daniele Marcello, Fabrizio Di Benedetto, Marina Marzola, Fabrizio D’Acapito, Guglielmo Nasti, Massimiliano Berretta. Is It Possible a Conservative Approach After Radiochemotherapy in Locally Advanced Rectal Cancer (LARC)? A Systematic Review of the Literature and Meta-analysis. Journal of Gastrointestinal Cancer 2019; 50(1): 98 doi: 10.1007/s12029-017-0041-8
|
| 45 |
Alessandro Ottaiano, Alfonso De Stefano, Monica Capozzi, Anna Nappi, Chiara De Divitiis, Carmela Romano, Lucrezia Silvestro, Antonino Cassata, Rossana Casaretti, Salvatore Tafuto, Michele Caraglia, Massimiliano Berretta, Guglielmo Nasti, Antonio Avallone. First Biologic Drug in the Treatment of RAS Wild-Type Metastatic Colorectal Cancer: Anti-EGFR or Bevacizumab? Results From a Meta-Analysis. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00441
|
| 46 |
AyaS Ali, DuaaS Helal, DareenA Mohamed, FersanA Sallam. Immunohistochemical expression of FAP and PCNA in neoplastic epithelial colonic lesions. Tanta Medical Journal 2022; 50(3): 236 doi: 10.4103/tmj.tmj_53_20
|
| 47 |
Jesús Daniel Fernández-de Castro, Franco Baiocchi Ureta, Raquel Fernández González, Noel Pin Vieito, Joaquín Cubiella Fernández. The effect of delay on the prognosis of colorectal cancer. Gastroenterología y Hepatología (English Edition) 2019; 42(9): 527 doi: 10.1016/j.gastre.2019.03.020
|
| 48 |
Qian-Qian Yu, Hong Qiu, Ming-Sheng Zhang, Guang-Yuan Hu, Bo Liu, Liu Huang, Xin Liao, Qian-Xia Li, Zhi-Huan Li, Xiang-Lin Yuan. Predictive effects of bilirubin on response of colorectal cancer to irinotecan-based chemotherapy. World Journal of Gastroenterology 2016; 22(16): 4250-4258 doi: 10.3748/wjg.v22.i16.4250
|
| 49 |
Linhao Zhang, Zhiyin Huang, Qiuyu Cai, Chong Zhao, Yang Xiao, Xin Quan, Chengwei Tang, Jinhang Gao. Inhibition of Transketolase Improves the Prognosis of Colorectal Cancer. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.837143
|
| 50 |
Ulrich-Axel Bommer, Kara L. Vine, Prianka Puri, Martin Engel, Lisa Belfiore, Karen Fildes, Marijka Batterham, Alistair Lochhead, Morteza Aghmesheh. Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin. Cell Communication and Signaling 2017; 15(1) doi: 10.1186/s12964-017-0164-3
|
| 51 |
Cheng-Jiang Liu, Ting Hu, Ping Shao, Wu-Yang Chu, Yu Cao, Feng Zhang, Naohisa Yoshida. TAS-102 Monotherapy and Combination Therapy with Bevacizumab for Metastatic Colorectal Cancer. Gastroenterology Research and Practice 2021; 2021: 1 doi: 10.1155/2021/4014601
|
| 52 |
Jan Kral, Vlasta Korenkova, Vendula Novosadova, Lucie Langerova, Michaela Schneiderova, Vaclav Liska, Miroslav Levy, Veronika Veskrnova, Julius Spicak, Alena Opattova, Katerina Jiraskova, Veronika Vymetalkova, Pavel Vodicka, Jana Slyskova. Expression profile of miR-17/92 cluster is predictive of treatment response in rectal cancer. Carcinogenesis 2018; 39(11): 1359 doi: 10.1093/carcin/bgy100
|
| 53 |
Hiroshi Doi, Hiroyuki Yokoyama, Naohito Beppu, Masayuki Fujiwara, Shogo Harui, Ayako Kakuno, Hidenori Yanagi, Yoshio Hishikawa, Naoki Yamanaka, Norihiko Kamikonya. Neoadjuvant Modified Short-Course Radiotherapy Followed by Delayed Surgery for Locally Advanced Rectal Cancer. Cancers 2021; 13(16): 4112 doi: 10.3390/cancers13164112
|
| 54 |
Homood M. As Sobeai, Munirah Alohaydib, Ali R. Alhoshani, Khalid Alhazzani, Mashal M. Almutairi, Tareq Saleh, David A. Gewirtz, Moureq R. Alotiabi. Sorafenib, rapamycin, and venetoclax attenuate doxorubicin-induced senescence and promote apoptosis in HCT116 cells. Saudi Pharmaceutical Journal 2022; 30(1): 91 doi: 10.1016/j.jsps.2021.12.004
|
| 55 |
Jiewei Chen, Qingmei He, Peishan Wu, Jianchang Fu, Yongbo Xiao, Keming Chen, Dan Xie, Xinke Zhang. ZMYND8 expression combined with pN and pM classification as a novel prognostic prediction model for colorectal cancer: Based on TCGA and GEO database analysis. Cancer Biomarkers 2020; 28(2): 201 doi: 10.3233/CBM-191261
|
| 56 |
Nazım Demircan, Osman Köstek, Ali Gökyer, Ahmet Küçükarda, Muhammet Hacıoğlu, Bülent Erdoğan, Sernaz Uzunoğlu, İrfan Çiçin. The albumin-bilirubin (ALBI) grade as a significant prognostic factor in colorectal cancer patients with liver metastases. Journal of Surgery and Medicine 2019; doi: 10.28982/josam.597751
|
| 57 |
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Colorectal Metastases. Annals of Surgical Oncology 2020; 27(6): 1761 doi: 10.1245/s10434-020-08315-x
|
| 58 |
Chi‐Ruei Huang, Yu‐Ting Chu, Chia‐Lo Chang, Hon‐Kan Yip, Hong‐Hwa Chen. ZNF746 plays cardinal roles on colorectal cancer (CRC) cell invasion and migration and regulates mitochondrial dynamics and morphological changes of CRC cells—Role of combined melatonin and 5‐FU regimen. Journal of Cellular Biochemistry 2024; 125(2) doi: 10.1002/jcb.30507
|
| 59 |
Safia El Messaoudi, Florent Mouliere, Stanislas Du Manoir, Caroline Bascoul-Mollevi, Brigitte Gillet, Michelle Nouaille, Catherine Fiess, Evelyne Crapez, Frederic Bibeau, Charles Theillet, Thibault Mazard, Denis Pezet, Muriel Mathonnet, Marc Ychou, Alain R. Thierry. Circulating DNA as a Strong Multimarker Prognostic Tool for Metastatic Colorectal Cancer Patient Management Care. Clinical Cancer Research 2016; 22(12): 3067 doi: 10.1158/1078-0432.CCR-15-0297
|
| 60 |
Özgen Arslan Solmaz. Prognostic significance of the tumor-stroma ratio in colon carcinoma: a retrospective study. Archives of Medical Science – Civilization Diseases 2018; 3(1): 190 doi: 10.5114/amscd.2018.81186
|
| 61 |
Feng Que, Hua Wang, Yi Luo, Li Cui, Lanfu Wei, Zhaohong Xi, Qiu Lin, Yongsheng Ge, Wei Wang. Comprehensive Analysis of Differentially Expressed circRNAs Reveals a Colorectal Cancer-Related ceRNA Network. Computational and Mathematical Methods in Medicine 2020; 2020: 1 doi: 10.1155/2020/7159340
|